Purchase Order HHSN269201600095M
- Not listed
- This is a $14,856.75 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The award is for the provision of reagents and kits, with an ultimate completion date of May 28, 2025. Biolegend has previously served as a subcontractor to Parsons Government Services Inc. on...
- This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other life science research products. The $3,472.00 contract, awarded on July 13, 2012, is for the delivery of various specialized antibodies, reagents, and kits to support research initiatives across multiple federal...
- This $13,265.25 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the supply of antibodies and kits to support cell isolation research that may affect the immune system. Biolegend is a specialized supplier of products used in immunology, oncology, neuroscience, and cell biology...
- This firm-fixed-price purchase order contract, valued at $14,906.75, was awarded by the National Cancer Institute to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products. The contract is for the delivery of 30 different antibodies to support multi-parameter flow cytometric analyses of circulating immune subsets in over 230 clinical samples as part of a clinical trial protocol. The contract does not have a set-aside...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other scientific research products located in San Diego, California. The contract is for the procurement of biological and reagent materials, specifically Biolegend flow cytometer antibodies, with a ceiling value of $14,042.25...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Biolegend, Inc. for the supply of various biomedical research reagents and antibodies. The $3,088.75 contract supports research efforts across multiple federal agencies, particularly within the NIAID. Biolegend, a for-profit manufacturer of life science research products, has a history of providing specialized...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The $16,199.95 contract is for the delivery of BIOLEGEND antibodies to support NIAID's research initiatives, which may include studies related to COVID-19, immunology, and other disease areas. The contract does not...
- This is a firm fixed-price BPA call contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other scientific research products. The $15,405.00 contract is for the delivery of OGLIO-CONJUGATED REAGENTS, which are specialized biological materials used in scientific research. The contract does not have a...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products for life science research and drug discovery. The $3,500.51 contract is to provide a variety of specialized reagents and products, such as oligonucleotide-tagged antibodies, TotalSeq antibody panels, and custom human antibody panels, to support research initiatives across multiple NIH components, including the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and NIH Clinical Center. This contract award does not have a set-aside designation. Biolegend, Inc. is a subsidiary of the parent company Revvity Inc., which also supports federal research through prime contract awards and subcontracts, primarily in the areas of medical imaging, automation applications, and liquid chromatography systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | ($44) | 8/24/23 | |
| P00002 | Funding Only Action | ($195) | 9/26/22 | |
| 1 | Other Administrative Action | $240 | 11/2/16 | |
| Not listed | Not listed | $3.5k | 8/22/16 |